These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Surgery for cancer with mediastinal lymph node invasiveness (N2)].
    Author: Riquet M, Saab M.
    Journal: Rev Pneumol Clin; 1992; 48(5):197-200. PubMed ID: 1303579.
    Abstract:
    Resection is indicated in about 20% of N2 cases. When it is complete a 5-year survival rate may be expected. It represents for these patients a chance of cure and therefore must be considered in all cases of N2, either immediately or after an adjuvant treatment. Its results can be improved by strict selection of the patients and by an efficient chemotherapy.
    [Abstract] [Full Text] [Related] [New Search]